pitavastatin + pitavastatin single dose combined with ceftobiprole
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug-drug Interaction Study
Conditions
Drug-drug Interaction Study
Trial Timeline
Jan 17, 2025 → Feb 25, 2025
NCT ID
NCT06808646About pitavastatin + pitavastatin single dose combined with ceftobiprole
pitavastatin + pitavastatin single dose combined with ceftobiprole is a phase 1 stage product being developed by Basilea Pharmaceutica for Drug-drug Interaction Study. The current trial status is completed. This product is registered under clinical trial identifier NCT06808646. Target conditions include Drug-drug Interaction Study.
Hype Score Breakdown
Clinical
6
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06808646 | Phase 1 | Completed |
Competing Products
15 competing products in Drug-drug Interaction Study